RTL4, a Retrovirus-Derived Gene Implicated in Autism Spectrum Disorder, Is a Microglial Gene That Responds to Noradrenaline in the Postnatal Brain

Int J Mol Sci. 2024 Dec 23;25(24):13738. doi: 10.3390/ijms252413738.

Abstract

Retrotransposon Gag-like 4 (RTL4), a gene acquired from a retrovirus, is a causative gene in autism spectrum disorder. Its knockout mice exhibit increased impulsivity, impaired short-term spatial memory, failure to adapt to novel environments, and delayed noradrenaline (NA) recovery in the frontal cortex. However, due to its very low expression in the brain, it remains unknown which brain cells express RTL4 and its dynamics in relation to NA. We addressed these issues using knock-in mice carrying endogenous Rtl4 fused to Venus, which encodes a fluorescent protein. The RTL4-Venus fusion protein was detected as a secreted protein in the midbrain, hypothalamus, hippocampus and amygdala in the postnatal brain. Its signal intensity was high during critical periods of neonatal adaptation to novel environments. It was upregulated by various stimuli, including isoproterenol administration, whereas it was decreased by anesthesia but was maintained by milnacipran administration, suggesting its highly sensitive response to stressors, possible dependence on the arousal state and involvement in the NA reuptake process. In vitro mixed glial culture experiments demonstrated that Rtl4 is a microglial gene and suggested that RTL4 secretion responds rapidly to isoproterenol. Microglial RTL4 plays an important role in the NA response and possibly in the development of the NAergic neuronal network in the brain.

Keywords: Rtl4-Venus knock-in mouse; Rtl4/Sirh11; autism spectrum disorder (ASD); eutherian brain evolution; exaptation; microglia; noradrenaline (NA); postanal brain; retrovirus-derived genes.

MeSH terms

  • Animals
  • Autism Spectrum Disorder* / genetics
  • Autism Spectrum Disorder* / metabolism
  • Brain* / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microglia* / metabolism
  • Norepinephrine* / metabolism

Substances

  • Norepinephrine

Grants and funding

This work was supported by a funding program for Next Generation World-Leading Researchers (NEXT Program LS112) and Grants-in-Aid for Scientific Research (C) (17K07243 and 21K06127) from the Japan Society for the Promotion of Science (JSPS) to T.K.-I., Grants-in-Aid for Scientific Research (S) (23221010) and (A) (16H02478 and 19H00978) and for Challenging Research (Pioneering) (20K20584) from JSPS to F.I., and funding from the Nanken Kyoten Program, Medical Research Institute, Tokyo Medical and Dental University (TMDU), to T.K.-I. and F.I. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.